With the development of the traditional Chinese medicine industry, pharmaceutical companies urgently need to transform and upgrade

In recent years, favorable policies for the development of Chinese medicine in China have been continuously introduced
.
Affected by this, under the current promulgation of a series of policies and regulations such as the "Traditional Chinese Medicine Law", the "Outline of the Strategic Plan for the Development of Traditional Chinese Medicine (2016-2030)", and "Several Policies and Measures on Accelerating the Development of Chinese Medicine with Characteristics", China's The development of the Chinese medicine industry has also begun to usher in good development opportunities
.
According to the "In-depth Research and Investment Prospect Analysis Report of the Traditional Chinese Medicine Industry Market 2021-2025" released by the New Thinking Industry Research Center, the scale of China's traditional Chinese medicine manufacturing market has increased from 64 billion yuan to 73.
5 billion yuan from 2016 to 2020.
, The average annual compound growth rate reached 3.
6% or more
.
In the future, driven by favorable policies, by 2023, the size of the Chinese medicine market is expected to reach RMB 22,36.
77 billion
.
But it is worth noting that while favorable policies have brought opportunities for the development of Chinese medicine, they have also brought more challenges
.
It is understood that the traditional Chinese medicine industry has always had problems such as focusing on sales rather than R&D, weak overall competitiveness, and insufficient corporate innovation vitality
.
Therefore, in the context of medical insurance control fees, the industry generally believes that traditional Chinese medicine companies urgently need to innovate and transform.
In the new era of traditional Chinese medicine innovation, it is necessary to integrate traditional Chinese medicine theory, academics and modern science and technology to promote the modernization and industrialization of Chinese medicine.

.
The analysis believes that the modernization and industrialization of Chinese medicine should make breakthroughs in the following aspects
.
First of all, Chinese medicine enterprises should apply modern scientific and technological achievements to Chinese medicine, enrich the theory of Chinese medicine, update Chinese medicine technology, and use new intelligent equipment and instruments to serve the people's health more safely and effectively
.
Second, the state and enterprises should accelerate the modernization and industrialization of the cultivation of Chinese medicinal materials
.
Among them, the state should revise and improve the quality standards and specifications of artificially planted Chinese medicinal materials as soon as possible, strengthen the quality control of Chinese medicinal materials, strengthen the environmental protection of Chinese medicinal materials, and promote ecological planting, wild planting and bionic planting
.
Enterprises should increase investment in the cultivation of Chinese herbal medicines and set up large-scale planting production bases
.
Efforts to improve the quality and efficiency, increase the income of the planting industry
.
In addition, Chinese medicine companies should also accelerate the modernization and industrialization of Chinese patent medicine research and development
.
Using modern technology to extract and synthesize the effective ingredients of Chinese herbal medicines, we have developed and produced more products such as Chinese patent medicines and traditional Chinese medicine formula granules with definite curative effects
.
In fact, in the face of fierce competition in the Chinese medicine market, adulteration of Chinese medicinal materials, and repeated prohibitions on low-price vicious competition, many Chinese medicine companies have begun to break the situation by promoting their own modernization and industrialization
.
Since 2018, Foci Pharmaceuticals has been vigorously promoting the construction of smart factories and digital workshops while introducing advanced automated production equipment and expanding production scale
.
In addition, in recent years, it has also begun to provide information on China’s formulation of natural medicine quality standards and adverse reaction monitoring reports to relevant parties in Brazil and other countries for the reference of the other party.
It serves as a bridge for international cooperation in traditional Chinese medicine
.
In general, with the support of a series of favorable policies, the pace of development of Chinese medicine is accelerating
.
Affected by this, the Chinese medicine industry will also accelerate its modernization and standardized development in the future
.
For traditional Chinese medicine companies, it is necessary to accelerate reforms and continuously improve product quality through innovation and scientific means in order to smoothly embark on the road of modernization and industrialization
.